Effectiveness of 1 dose of 2009 influenza A (H1N1) vaccine at preventing hospitalization with pandemic H1N1 influenza in children aged 7 months-9 years

Journal of Infectious Diseases

Volumn 206, Issue 1, 2012, Pages 49-55

  Hadler, James L ^a   Baker, Tai N ^a,b,c   Papadouka, Vikki ^a   France, Anne Marie ^a,c   Zimmerman, Christopher ^a   Livingston, Kara A ^a,c,e   Zucker, Jane R ^a,d  

^a NEW YORK CITY DEPARTMENT OF HEALTH AND MENTAL HYGIENE   (United States)

^b Scientific Education and Professional Development Program Office   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^d NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

^e TUFTS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE;

2009 H1N1 INFLUENZA; AGE DISTRIBUTION; ARTICLE; CASE CONTROL STUDY; CHILD; CHILD HEALTH CARE; CHILD HOSPITALIZATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; FEMALE; HUMAN; IMMUNOGENICITY; INFANT; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIMARY PREVENTION; PRIORITY JOURNAL; SCHOOL CHILD; SINGLE DRUG DOSE; TREATMENT RESPONSE; VACCINATION;

CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; HOSPITALIZATION; HUMANS; INFANT; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; NEW YORK CITY; PANDEMICS; REGISTRIES;

EID: 84861533950     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jis306     Document Type: Article

References (16)

1. Centers for Disease Control and Prevention. Update: influenza activity-United States, August 30, 2009-March 27, 2010, and composition of the 2010-2011 influenza vaccine. MMWR Morb Mortal Wkly Rep 2010; 59:423-30.
2. Food and Drug Administration. FDA approves vaccines for 2009 H1N1 influenza virus: approval provides important tool to fight pandemic. FDA news release, September 15, 2009. http://www.fda.gov/newsevents/newsroom/ pressannouncements/ucm182399.htm. Accessed 7 May 2012.
3. Centers for Disease Control and Prevention. Use of influenza A (H1N1) 2009 monovalent vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009. MMWR Morb Mortal Wkly Rep 2009; 58:1-8.
4. Centers for Disease Control and Prevention. Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010. MMWR Morb Mortal Wkly Rep 2010; 59:1-62.
5. New York City Department of Health and Mental Hygiene. New York City health code, section 11.04. http://www.nyc.gov/html/doh/downloads/pdf/cir/ healthcode2005.pdf. Accessed 7 May 2012.
6. Muhammed RD, Friedman CR, Taylor TH, et al. Using immunization information systems to evaluate effectiveness of pneumococcal conjugate vaccine among children. In: Program and abstracts of the 57th Annual Epidemic Intelligence Service Conference (Atlanta). Atlanta, GA: Centers for Disease Control and Prevention, 2008:33. http://www.cdc. gov/eis/downloads/2008.EIS. Conference.pdf. Accessed 7 May 2012.
7. Sahni LC, Boom JA, Patel MM, et al. Use of an immunization information system to assess the effectiveness of pentavalent rotavirus vaccine in US children. Vaccine 2010; 28:6314-7.
8. Guh AY, Hadler JL. Use of the state immunization information system to assess rotavirus vaccine effectiveness in Connecticut, 2006-2008. Vaccine 2011; 29(37):6155-8.
9. Plennevaux E, Sheldon E, Blatter M, Reeves-Hoche M, Denis M. Immune response after a single vaccination against 2009 influenza A H1N1 in USA: a preliminary report of two randomized controlled phase 2 trials. Lancet 2010; 375:41-8.
10. Zhu FC, Wang H, Fang HH, et al. A novel influenza A (H1N1) vaccine in various age groups. N Engl J Med 2009; 361:2414-23.
11. Nolan T, McVernon J, Skeljo M, et al. Immunogenicity of a monovalent 2009 influenza A (H1N1) vaccine in infants and children. JAMA 2010; 303:37-46.
12. Centers for Disease Control and Prevention. Immunization information systems progress-United States, 2006. MMWR Morb Mortal Wkly Rep 2008; 57:289-91.
13. Mahon BE, Shea KM, Dougherty NN, Loughlin AM. Implications for registry-based vaccine effectiveness studies from an evaluation of an immunization registry: a cross-sectional study. BMC Public Health 2008; 8:160.
14. Centers for Disease Control and Prevention. Effectiveness of U.S. influenza A(H1N1) 2009 monovalent vaccines in preventing health care visits associated with RT-PCR-confirmed 2009 H1N1 infections. Advisory Committee on Immunization Practices (ACIP) summary report, June 23-24, 2010. Atlanta, GA: Centers for Disease Control and Prevention, 2010:119-133. http://www.cdc.gov/ vaccines/recs/acip/downloads/min-archive/min-jun10.pdf. Accessed 7 May 2012.
15. Schuler CM, Iwanmoto M, Bridges CB, Marin M, Neeman R, et al. Vaccine effectiveness against medically attended, laboratory-confirmed influenza among children aged 6-59 months, 2003-2004. Pediatrics 2007; 119:e587-95.
16. Ritzwoller DP, Bridges CB, Shetterly S, Yamasaki S, Kolzach M, France EK. Effectiveness of the 2003-2004 influenza vaccine among children 6 months to 8 years of age with 1 vs 2 doses. Pediatrics 2005; 116:153-9.